Celyad SA (CYAD:NASDAQ) soared at $2.37, a gain of 24.7%. On Wed, Jan 18, 2023, CYAD:NASDAQ hit a New 2-Week High of $2.37. The stock got featured on our News Catalysts scanner on Wed, Dec 21, 2022 at 01:10 PM in the 'INVESTOR UPDATE' category. From Wed, Jan 04, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Wed, Jan 18, 2023 at $3.07 with a volume of 19M+.
About Celyad SA (CYAD:NASDAQ)
Celyad SA is a biopharmaceutical company. The company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.
Top 10 Gainers:
- Ontrak Inc. (OTRK:NASDAQ), 94.78%
- Magic Empire Global Limited (MEGL:NASDAQ), 44.29%
- Energy Vault Holdings Inc Com Cl A (NRGV:NYSE), 34.83%
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 32.95%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 27.79%
- Sema4 Holdings Corp. (SMFR:NASDAQ), 26.78%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 25.71%
- Draganfly Inc. (DPRO:NASDAQ), 25.47%
- Celyad SA (CYAD:NASDAQ), 24.74%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 23.23%